RadNet Net Income 2010-2025 | RDNT

RadNet net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
RadNet Annual Net Income
(Millions of US $)
2024 $3
2023 $3
2022 $11
2021 $25
2020 $-15
2019 $15
2018 $32
2017 $0
2016 $7
2015 $8
2014 $1
2013 $2
2012 $60
2011 $7
2010 $-13
2009 $-2
RadNet Quarterly Net Income
(Millions of US $)
2025-03-31 $-38
2024-12-31 $5
2024-09-30 $3
2024-06-30 $-3
2024-03-31 $-3
2023-12-31 $-2
2023-09-30 $18
2023-06-30 $8
2023-03-31 $-21
2022-12-31 $-1
2022-09-30 $1
2022-06-30 $8
2022-03-31 $3
2021-12-31 $-4
2021-09-30 $16
2021-06-30 $3
2021-03-31 $9
2020-12-31 $6
2020-09-30 $6
2020-06-30 $-11
2020-03-31 $-16
2019-12-31 $10
2019-09-30 $3
2019-06-30 $5
2019-03-31 $-4
2018-12-31 $29
2018-09-30 $5
2018-06-30 $5
2018-03-31 $-7
2017-12-31 $-7
2017-09-30 $3
2017-06-30 $5
2017-03-31 $-1
2016-12-31 $3
2016-09-30 $2
2016-06-30 $4
2016-03-31 $-1
2015-12-31 $1
2015-09-30 $8
2015-06-30 $3
2015-03-31 $-5
2014-12-31 $4
2014-09-30 $4
2014-06-30 $5
2014-03-31 $-12
2013-12-31 $1
2013-09-30 $0
2013-06-30 $3
2013-03-31 $-1
2012-12-31 $52
2012-09-30 $5
2012-06-30 $3
2012-03-31 $0
2011-12-31 $5
2011-09-30 $0
2011-06-30 $4
2011-03-31 $-1
2010-12-31 $3
2010-09-30 $0
2010-06-30 $-12
2010-03-31 $-4
2009-12-31 $1
2009-09-30 $-2
2009-06-30 $0
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.401B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.463B 19.18
Encompass Health (EHC) United States $12.251B 25.97
DaVita (DVA) United States $10.411B 14.64
Chemed (CHE) United States $8.228B 25.86
Elanco Animal Health (ELAN) United States $6.903B 14.79
Option Care Health (OPCH) United States $5.224B 23.28
Amedisys (AMED) United States $3.081B 20.73
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.082B 22.85
Astrana Health (ASTH) United States $1.416B 35.08
U.S Physical Therapy (USPH) United States $1.174B 30.29
Aveanna Healthcare Holdings (AVAH) United States $1.075B 61.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.483B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.045B 0.00
Daxor (DXR) United States $0.045B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00